Skip to content
Categories
Satellite Symposium
Satellite Symposium
Satellite Symposium

Exploring the Role of CDK4/6 Inhibitors in HR+ HER2- Breast Cancer: From the Adjuvant to the Metastatic Setting

- , Boston 1-2

Schedule Slot

Exploring the Role of CDK4/6 Inhibitors in HR+ HER2- Breast Cancer: From the Adjuvant to the Metastatic Setting

Categories
Satellite Symposium
Satellite Symposium
Satellite Symposium

Exploring the Role of CDK4/6 Inhibitors in HR+ HER2- Breast Cancer: From the Adjuvant to the Metastatic Setting

- , Boston 1-2

Endorsed by: Novartis Pharma Schweiz AG